Who owns CDT - CONDUIT PHARMACEUTICALS INC. - Common Stock based on 13F filings?

Open this security page to review the newest available 13F ownership history, top reported holders, and period-by-period changes.

CONDUIT PHARMACEUTICALS INC. - Common Stock (CDT) Institutional Ownership

Q: What is CUSIP 20678X205?

CUSIP 20678X205 is the security identifier used in SEC filing datasets for CDT - CONDUIT PHARMACEUTICALS INC. - Common Stock.

CUSIP: 20678X205

13F Institutional Holders and Ownership History from Q4 2024 to Q2 2025

Type / Class: Equity / Common Stock
Symbol: CDT on Nasdaq
Shares outstanding: 11,304,470
Price per share: $0.39
Price from insider filings: $0.39

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Investment Quick Answers

What is CUSIP 20678X205?
CUSIP 20678X205 identifies CDT - CONDUIT PHARMACEUTICALS INC. - Common Stock in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Continue Investment Research

Latest 13F filings for new institutional portfolio disclosures.
Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
Latest 10-Q/10-K reports to cross-check issuer fundamentals.
Recent insider transactions for management buying/selling context.
SEC investors directory and top value investors for manager-level discovery.
All institutional ownership pages to compare adjacent CUSIP pages.

Recent Quarterly Holder Reports

Open recent reporting periods for CUSIP 20678X205:

Q2 2025 (0 holders) Q1 2025 (31 holders) Q4 2024 (1 holder)

Significant Owners of CONDUIT PHARMACEUTICALS INC. - Common Stock (CDT) based on Schedule 13D/G filings

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
Sarborg Ltd	16%		$1,038,202		1,853,933		Sarborg Ltd	31 Mar 2025
A.G.P. / ALLIANCE GLOBAL PARTNERS, LLC	9.8%		$620,659		1,108,320		A.G.P. / Alliance Global Partners, LLC	31 Mar 2025

Institutional Holders of CONDUIT PHARMACEUTICALS INC. - Common Stock (CDT) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Price (Median)	Investors
2025 Q2	0	$0	-$384,917	$0.39	0
2025 Q1	493,468	$385,113	+$383,312	$0.78	31
2024 Q4	2,006	$138		$0.07	1